Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Recruiting now · Not applicable
Conditions studied: Gastrointestinal Neoplasm Malignant
In brief
This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
Key facts
- Study ID
- NCT06002425
- Run by
- Chinese Academy of Sciences
- People needed
- 400
- Starts
- 2023-08-29
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2023-09-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years, both male and female.
- Pathologically confirmed diagnosis of gastrointestinal cancer (gastric cancer or colorectal Cancer).
- Detailed medical records available prior to treatment (including chief complaint, history of present illness, radiological examinations, pathological examinations, laboratory tests, etc.).
- Participants will receive complete treatment in the participating hospitals.
You may not qualify if…
- Participants with cancers other than gastrointestinal cancers.
- Participants who receive treatment in multiple hospitals.
Where it is running
- Zhuhai People's Hospital — Zhuhai, Guangdong, China (enrolling)
- Jiangmen Central Hospital — Jiangmen, Guangdong, China (enrolling)
- The Fifth Affiliated Hospital of Sun Yat-sen University — Zhuhai, Guangdong, China (enrolling)
- Peking University Cancer Hospital (Inner Mongolia Campus) — Hohhot, Inner Mongolia, China (enrolling)
- San Raffaele University Hospital, Italy — Milan, Italy
- University Hospital Magdeburg — Magdeburg, Saxony-Anhalt, Germany
- City of Hope — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.